Douglas Fambrough Insider Profile
4 Followers
Douglas Fambrough, former CEO, Director at Dicerna Pharma, holds 231.43K shares in Dicerna Pharma (Ticker: DRNA), holds ― shares in Oncorus (Ticker: ONCR).
Douglas Fambrough's Trading History
| DRNADicerna Pharma | Aug 10, 2021 | ― | Uninformative Buy | 110.45K | $8.85M | |
| ONCROncorus | ― | ― | ― | ― |
You May Also Like
Douglas Fambrough insider profile FAQ
What is the percentage of profitable transactions made by Douglas Fambrough?
The percentage of profitable transactions made by Douglas Fambrough is 25%.
What is the average return per transaction made by Douglas Fambrough?
The average return per transaction made by Douglas Fambrough is -22.50%.
What stocks does Douglas Fambrough hold?
Douglas Fambrough holds: DRNA, ONCR stocks.
What was Douglas Fambrough’s latest transaction?
Douglas Fambrough’s latest transaction was an Uninformative Buy of $110.45K.
What was Douglas Fambrough's most profitable transaction?
Douglas Fambrough’s most profitable transaction was an Informative Buy of DRNA stock on September 1, 2020. The return on the trade was 13.70%.
What is Douglas Fambrough's role in Dicerna Pharma?
Douglas Fambrough's role in Dicerna Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
